Yunyi Bian

miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways

Guoshu Bi, Jiaqi Liang, Mengnan Zhao et al. · Molecular Therapy — Nucleic Acids · 2022 · 109 citations · Full text

Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer

Guoshu Bi, Jiaqi Liang, Yunyi Bian et al. · Nature Communications · 2024 · 92 citations · Full text

The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers

Tengteng Wei, Guoshu Bi, Yunyi Bian et al. · Frontiers in Molecular Biosciences · 2020 · 64 citations · Full text

Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy

Zhencong Chen, Yiwei Huang, Zhengyang Hu et al. · Oncogenesis · 2021 · 59 citations · Full text

MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma

Jiaqi Liang, Guoshu Bi, Yiwei Huang et al. · Drug Resistance Updates · 2024 · 59 citations

Cell Cycle Progression, Radiation Therapy, Medicine +9